HALO Link

Indica Labs and Visiopharm Deliver an Integrated Digital Pathology Image Management and Analysis Solution

Albuquerque, NM and Hørsholm, Denmark, April 9, 2025 – Indica Labs and Visiopharm today announce the successful integration of Visiopharm’s Discovery image analysis software into Indica’s collaborative image management platform, HALO Link. The integration will enable laboratories to create a customized digital pathology ecosystem optimized for their unique image analysis and collaboration needs.

Indica Labs and Visiopharm Deliver an Integrated Digital Pathology Image Management and Analysis Solution Read More »

Open Pathology and AI Integrations: Empowering Labs with Choice

In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.

Open Pathology and AI Integrations: Empowering Labs with Choice Read More »

HALO®, HALO AI, and HALO Link 4.1 Sneak Peek

20 March 2025 | Learn about the powerful new features coming soon in the 4.1 versions of HALO, HALO AI, and HALO Link! This webinar will showcase the latest advancements in HALO, HALO AI, and HALO Link 4.1 designed to enhance workflow efficiency for multiplexed image analysis.

HALO®, HALO AI, and HALO Link 4.1 Sneak Peek Read More »

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform

Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform Read More »

Scroll to Top